Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
STAMFORD, Conn., Jan. 03, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, at 11:15 a.m. PST (2:15 p.m. EST) in San Francisco, CA.
Related news for (CARA)
- Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
- Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
- 24/7 Market News Snapshot 18 December, 2024 – Cara Therapeutics, Inc. (NASDAQ:CARA)
- Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
